References
- Smith CR, Leon MB, Mack M, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa1103510.
- Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–1620. doi:10.1056/NEJMoa1514616.
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–1705. doi:10.1056/NEJMoa1814052.
- Dahle T, Kaneko Y, McCabe J. Outcomes following subclavian and axillary artery access for transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12(7):662–669. doi:10.1016/j.jcin.2019.01.219.
- Dahle T, Castro N, Stegman B, et al. Supraclavicular subclavian access for SAPIEN transcatheter aortic valve replacement- a novel approach. JCTS. 2018;13:16.
- Mathur M, Krishnan SK, Levin D, Aldea G, Reisman M, McCabe JM. A step-by-step guide to fully percutaneous transaxillary transcatheter aortic valve replacement. Struct Heart. 2017;00:1–7.
- Schafer U, Ho Y, Frerker C, et al. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation. J Am Coll Cardiol Intventions. 2012;5(5):477–486. doi:10.1016/j.jcin.2011.11.014.
- Mylotte D, Sudre A, Teiger E, et al. Transcarotid transcatheter aortic valve replacement: feasibility and safety. JACC Cardiovasc Interv. 2016;9(5):472–480. doi:10.1016/j.jcin.2015.11.045.
- Greenbaum A, Babaliaros V, Chen M, et al. Transcaval access and closure for transcatheter aortic valve replacement- a prospective investigation. J Am Coll Cardiol. 2017;2017(69):511–521.
- Holmes DR Jr, Nishimura RA, Grover FL, et al. Annual outcomes with transcatheter valve therapy: from the STS/ACC TVT registry. J Am Coll Cardiol. 2015 Dec 29;66(25):2813–2823. doi:10.1016/j.jacc.2015.10.021.
- Thourani VH, Jensen HA, Babaliaros V, et al. Transapical and transaortic transcatheter aortic valve replacement in the United States. Ann Thorac Surg. 2015 Nov;100(5):1718–1726. doi:10.1016/j.athoracsur.2015.05.010.
- Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010;3(4):359–366. doi:10.1161/CIRCINTERVENTIONS.109.930453.
- Petronio AS, De Carlo M, Bedogni F, et al. Two-year results of CoreValve implantation through the subclavian access: a propensity-matched comparison with the femoral access. J Am Coll Cardiol. 2012;60(6):502–507. doi:10.1016/j.jacc.2012.04.014.
- Muensterer A, Mazzitelli D, Ruge H, et al. Safety and efficacy of the subclavian access route for TAVI in cases of missing transfemoral access. Clin Res Cardiol. 2013;102(9):627–636. doi:10.1007/s00392-013-0575-0.
- Fröhlich GM, Baxter PD, Malkin CJ, et al. Comparative survival after trans-apical, direct aortic, and subclavian transcatheter aortic valve implantation. Am J Cardiol. 2015;116(10):1555–1559. doi:10.1016/j.amjcard.2015.08.035.
- Ciuca C, Tarantini G, Latib A, et al. Trans-subclavian versus transapical access for transcatheter aortic valve implantation: a multicenter study. Catheterization Cardiovasc Interventions. 2016;87(2):332–338. doi:10.1002/ccd.26012.
- Gleason TG, Schindler J, Hagberg RC, et al. Subclavian/axillary access for self-expanding transcatheter aortic valve replacement renders equivalent outcomes as transfemoral. Ann Thoracic Surgery. 2018;105(2):477–483. doi:10.1016/j.athoracsur.2017.07.017.
- Schafer U, Deuschl F, Schofer N, et al. Safety and efficacy of the percutaneous transaxillary access for transcatheter aortic valve implantation using various transcatheter heart valves in 100 consecutive patients. Int J Cardiol. 2017;2017(232):247–254.
- Herrmann HC, Thourani VH, Kodali SK, et al. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation. 2016;134(2):130–140. doi:10.1161/CIRCULATIONAHA.116.022797.
- Thourani VH, Kodali S, Makkar RR, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. Lancet. 2016;387(10034):2218–2225.
- Vermulapalli S, Carroll KJD, Mack MJ, et al. Procedural volume and outcomes for transcatheter aortic-valve replacement. N Engl J Med. 2019;380(26):2541–2550. doi:10.1056/NEJMsa1901109.
- McCabe JM, Huang PH, Cohen DJ, et al. Surgical versus percutaneous femoral access for delivery of large-bore cardiovascular devices (from the PARTNER trial). Am J Cardiol. 2016;117:1643–1650.
- Arnett DM, Lee JC, Harms MA, et al. Caliber and fitness of the axillary artery as a conduit for large-bore cardiovascular procedures. Catheter Cardiovasc Interv. 2017;91(1):150–156. doi:10.1002/ccd.27416.
- Tayal R, Iftikhar H, LeSar B, et al. CT angiography analysis of axillary artery diameter versus common femoral artery diameter: implications for axillary approach for transcatheter aortic valve replacement in patients with hostile aortoiliac segment and advanced lung disease. Int J Vasc Med. 2016;2016: 3610705–5.
- Hermiller J, Heimansohn D, Moainie S, et al. Trans-carotid versus subclavian/axillary access for transcatheter aortic valve replacement: real world comparative outcomes utilizing the STS/ACC TVT registry. Transcatheter Therapeutics Conference Sept 2019; San Francisco, CA, Oral Abstract:TCT–77.